Queen Elizabeth Hospital
Kowloon, Hong Kong
NCT Number: NCT03909841
This study was set out 1) Evaluate the impact of Diabetic Peripheral Neuropathy (DPN) and DPN-P (Diabetic Peripheral Neuropathic Pain) on the overall Quality of Life (QoL) in elderly with Diabetic Mellitus (DM) and 2) Evaluate the association between cognition impairments and DM in the elderly, and the contributions of DPN and/or DPN-P
Looking for future studies?
Notify Me50 year and older
All sexes
Observational
Kowloon, Hong Kong
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognition using Cambridge Neuropsychological Test Automated Battery (CANTAB)
Quality of Life using Chinese (Hong Kong) 12-item Short-Form Health Survey (version 2)
Time frame: Day 1
Identifying cognitive affected domains by using Cambridge Neuropsychological Test Automated Battery (CANTAB) (Reaction Time : RTI, Spatial Working Memory : SWM and Executive Function : OTS)
Time frame: Day 1
Identifying Quality of Life affected domains by using The Chinese (Hong Kong) 12-item Short-Form Health Survey version 2
Queen Elizabeth Hospital, Hong Kong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02738671
Body Weight, Cognition Disorders
Nanjing, Jiangsu, China
View Trial DetailsNCT04040634
Cardiovascular Diseases, Cognition Disorders
Maceió, Alagoas, Brazil
View Trial DetailsNCT06813274
Cardiovascular Diseases, Cognition Disorders
Chengdu, Sichuan, China
View Trial DetailsNCT07151430
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details